Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT(2A) antagonists amperozide and FG 5974

Alcoholism: Clinical and Experimental Research

Volumn 21, Issue 8, 1997, Pages 1448-1454

  Overstreet, David H ^a   McArthur, Robert A ^b   Rezvani, Amir H ^a   Post, Claes ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

5 HT(1A) Agonism; 5 HT(2A) Antagonists; Alcohol Preferring Rats; Amperozide; FG 5974

Indexed keywords

2 [4 [4,4 BIS(4 FLUOROPHENYL)BUTYL] 1 PIPERAZINYL]NICOTINIC ACID; AMPEROZIDE; SACCHARIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FLUID INTAKE; FOOD INTAKE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TASTE AVERSION;

EID: 0030657594     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1997.tb04475.x     Document Type: Article

References (32)

1. Sellers EM, Higgins GA, Sobell MB: 5-HT and alcohol abuse. Trends Pharmacol Sci 13:69-75, 1992
2. Gill K, Amit Z: Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies. Recent Dev Alcohol 7:225-248, 1989
3. LeMarquand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies. Biol Psychiatry 36:395-421, 1994
4. LeMarquand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: Clinical evidence. Biol Psychiatry 36:326-337, 1994
5. Kranzler HR, Purlieus JA, Del Poco FK, Abhor TF, Korner P, Brown J, Bohn MJ: Buspirone treatment of anxious alcoholics. Arch Gen Psychiatry 31:720-731, 1994
6. Tomkins DM, Higgins GA, Sellers EM: Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) increase ethanol intake. Psychopharmacology 15:173-179, 1994
7. Schreiber R, Opitz K, Glaser T, De Vry J: Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: Involvement of presynaptic 5-HT1A receptors. Psychopharmacology 112:100-110, 1993
8. Panocka I, Massi M: Long-lasting suppression of alcohol preference in rats following serotonin receptor blockade by ritanserin. Brain Res Bull 28:493-496, 1992
9. Myers RD, Lankford MF: Failure of the 5-HT2 receptor antagonist, ritanserin, to alter preference for alcohol in drinking rats. Pharmacol Biochem Behav 45:233-237, 1993
10. Panocka I, Ciccicioppo R, Pompei P, Massi M: 5-HT2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats. Pharmacol Biochem Behav 46:853-856, 1993
11. Svartengren J, Simonsson P: Receptor binding properties of amperozide. Pharmacol Toxicol 66 (Suppl 1):8-11, 1990
12. Albinsson A, Bjork A, Svartengren J, Klint Andersson G: Preclinical pharmacology of FG 5893: A potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors. Eur J Pharmacol 261:285-294, 1994
13. Svartengren JO: Selective down-regulation of the agonist-dependent high affinity state of rat cortical 5-HT receptors following chronic treatment with amperozide. J Recept Res 13:379-392, 1993
14. Gustafsson B, Christensson E: Amperozide - A new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour. Pharmacol Toxicol 66(Suppl 1):12-17, 1990
15. Myers RD, Lankford MF, Bjork A: Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide. Pharmacol Biochem Behav 43:661-667, 1992
16. Myers RD, Lankford MF, Bjork A: Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist, amperozide. Alcohol 10:117-125, 1993
17. Myers RD, Lankford MF, Bjork A: 5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats. Pharmacol Biochem Behav 45:741-747, 1993
18. Singh GK, Kalmus GW, Bjork AK, Myers RD: Alcohol drinking in rats is attenuated by the mixed 5-HT1 agonist/5-HT2 antagonist FG 5893. Alcohol 10:243-248, 1993
19. Andersson G, Albinsson A, Bjork A, Svartengren J: FG 5893: A potential new generation anxiolytic/antidepressant drug with high affinity for 5-HT1A and 5-HT2A receptors. CNS Drug Rev 2:363-389, 1996
20. Hjorth S, Pettersson G: 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG 5865 and FG 5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo. Eur J Pharmacol 238:357-367, 1993
21. Andersson G, Larsson K: Effects of FG 5893, a new compound with 5-HT1A receptor agonist and 5-HT2 receptor antagonist properties, on male rat sexual behavior. Eur J Pharmacol 255:131-137, 1994
22. Lankford MF, Bjork AK, Myers RD: Differential efficacy of serotonergic drugs FG 5974, FG 5893, and amperozide in reducing alcohol drinking in P rats. Alcohol 13:399-404, 1996
23. Overstreet DH, Rezvani AH, Kampov-Polevoy AB: Strain-dependent suppressant effects of dopaminergic, serotonergic and opioidergic agents on alcohol intake (abstr 666.16). Presented at the 25th Annual Meeting of the Society for Neuroscience, San Diego, CA, November 11-16, 1995
24. Rezvani AH, Overstreet DH, Mason GA: Heterogeneity and pharmacotherapy in four strains of alcohol-preferring rats. Presented at the 5th Annual Meeting of the International Behavioral Neuroscience Society, Cancun, Mexico, May 2-5, 1996
25. Rezvani AH, Grady DR: Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction. Pharmacol Biochem Behav 48:105-110, 1994
26. Rezvani AH, Overstreet DH, McArthur RA: Amperozide, a 5- HT2A receptor antagonist, is more effective in reducing alcohol intake than fluoxetine or duloxetine (abstr 456.13). Presented at the 26th Annual Meeting for the Society for Neuroscience, Washington, D.C., November 16-21, 1966
27. Roberts AJ, Hull EE, McArthur RA, Post C, Koob GF: Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol. Psychopharmacology (in press), 1997
28. Petterson E: Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro. Eur J Pharmacol 282:131-135, 1995
29. Tomkins DM, Fletcher PJ, Sellers EM: Median and dorsal rapine injections of the 5-HT-1A agonist, 8-OH-DPAT, and the GABA-A agonist, muscimol, increase voluntary ethanol intake in Wistar rats. Neuropharmacology 33:349-358, 1994
30. Dourish CT, Cooper SJ, Gilbert F, Coughlan J, Iversen SD: The 5-HT1A agonist 8-OH-DPAT increases consumption of palatable wet mash and liquid diets in the rat. Psychopharmacology 94:58-63, 1988
31. Ervin GN, Birkemo LS, Johnson MF, Conger LK, Mosher JT, Menius JA Jr: The effects of anorectic and aversive agents on deprivation-induced feeding and taste aversion conditioning in rats. J Pharmacol Exp Ther 273:1203-1210, 1995
32. Pucilowski O, Rezvani AH, Overstreet DH: The role of taste aversion in calcium channel inhibitor-induced suppression of saccharin and alcohol drinking in rats. Physiol Behav 59:319-314, 1996